TY  - CHAP
M1  - Book, Section
TI  - Reactive Erythemas
A1  - Shinkai, Kanade
A1  - Fox, Lindy P.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
PY  - 2021
T2  - Current Medical Diagnosis & Treatment 2021
AB  - Key  Clinical  Updates  in  Reactive  ErythemasLigelizumab  is  effective  for  chronic  urticaria  in  early  clinical  trials.Etanercept  is  emerging  as  a  promising  therapy  for  Stevens-Johnson  syndrome/toxic  epidermal  necrolysis  and  is  now  the  treatment  of  choice  in  some  centers.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2022/05/24
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1175804635
ER  -